Aehr Test Systems (AEHR) Competitors

Transcat (NASDAQ:TRNS) and Aehr Test Systems (NASDAQ:AEHR) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, community ranking, analyst recommendations, institutional ownership, media sentiment and dividends.

Do insiders & institutionals believe in TRNS or AEHR?

98.3% of Transcat shares are owned by institutional investors. Comparatively, 69.7% of Aehr Test Systems shares are owned by institutional investors. 2.3% of Transcat shares are owned by company insiders. Comparatively, 6.2% of Aehr Test Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Which has more risk & volatility, TRNS or AEHR?

Transcat has a beta of 0.7, meaning that its share price is 30% less volatile than the S&P 500. Comparatively, Aehr Test Systems has a beta of 1.94, meaning that its share price is 94% more volatile than the S&P 500.

Does the media refer more to TRNS or AEHR?

In the previous week, Aehr Test Systems had 25 more articles in the media than Transcat. MarketBeat recorded 27 mentions for Aehr Test Systems and 2 mentions for Transcat. Transcat's average media sentiment score of 1.51 beat Aehr Test Systems' score of 0.06 indicating that Transcat is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Transcat	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Aehr Test Systems	3 Very Positive mention(s)	1 Positive mention(s)	21 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Do analysts rate TRNS or AEHR?

Transcat presently has a consensus target price of $127.25, suggesting a potential upside of 23.02%. Aehr Test Systems has a consensus target price of $25.00, suggesting a potential upside of 102.59%. Given Aehr Test Systems' higher possible upside, analysts plainly believe Aehr Test Systems is more favorable than Transcat.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Transcat	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
Aehr Test Systems	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Which has preferable valuation and earnings, TRNS or AEHR?

Aehr Test Systems has lower revenue, but higher earnings than Transcat. Aehr Test Systems is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Transcat	$259.48M	3.67	$13.65M	$1.98	52.24
Aehr Test Systems	$66.22M	5.52	$33.16M	$0.98	12.59

Is TRNS or AEHR more profitable?

Aehr Test Systems has a net margin of 49.63% compared to Transcat's net margin of 6.63%. Aehr Test Systems' return on equity of 29.31% beat Transcat's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Transcat	6.63%	7.36%	5.90%
Aehr Test Systems	49.63%	29.31%	25.07%

Does the MarketBeat Community believe in TRNS or AEHR?

Transcat received 77 more outperform votes than Aehr Test Systems when rated by MarketBeat users. Likewise, 66.77% of users gave Transcat an outperform vote while only 58.41% of users gave Aehr Test Systems an outperform vote.

Company	Underperform	Outperform
Transcat	Outperform Votes 209 66.77%	Underperform Votes 104 33.23%
Aehr Test Systems	Outperform Votes 132 58.41%	Underperform Votes 94 41.59%

Summary

Transcat and Aehr Test Systems tied by winning 9 of the 18 factors compared between the two stocks.